| Gene Symbol | LINJ_36_1670 |
| Entrez Gene ID | 5073853 |
| Full Name | putative proteasome alpha 1 subunit |
| Gene Type | protein-coding |
| Organism | Leishmania infantum JPCM5 |
- REAGENT SERVICES Hot!
-
PRODUCTS
-
Most Popular Reagents
-
Instruments
-
Antibodies
-
ELISA Kits
-
Protein Electrophoresis and Blotting
-
Protein and Antibody Purification
-
Recombinant Proteins
-
Molecular Biology
-
Stable Cell Lines
-
Cell Isolation and Activation
-
IVD Raw Materials
-
Therapy Applications
-
Resources
-
![AmMag™ Quatro Automated Plasmid Purification]()
AmMag™ Quatro automated plasmid purification
-
![Anti-Camelid VHH]()
MonoRab™ Anti-VHH Antibodies
-
![ELISA Kits]()
ELISA Kits
-
![Precast Gels]()
SurePAGE™ Precast Gels
-
![Quatro ProAb Automated Protein and Antibody Purification System]()
AmMag™ Quatro ProAb Automated Protein and Antibody Purification System
-
![Target Proteins]()
Target Proteins
-
![AmMag™ Quatro Automated Plasmid Purification]()
AmMag™ Quatro automated plasmid purification
-
![Stable Cell Lines]()
Stable Cell Lines
-
![Cell Isolation and Activation]()
Cell Isolation and Activation
-
![Quick
Order]()
Quick Order
-
![Quick
Order]()
Quick Order
- APPLICATIONS
- RESOURCES
- ABOUT US
LINJ_36_1670 cDNA ORF clone, Leishmania infantum JPCM5
-
Gene
-
Clones
gRNAs
The following LINJ_36_1670 gene cDNA ORF clone sequences were retrieved from the NCBI Reference Sequence Database (RefSeq). These sequences represent the protein coding region of the LINJ_36_1670 cDNA ORF which is encoded by the open reading frame (ORF) sequence. ORF sequences can be delivered in our standard vector, pcDNA3.1+/C-(K)DYK or the vector of your choice as an expression/transfection-ready ORF clone. Not the clone you want? Click here to find your clone.
-
Reference Sequences (Refseq)
CloneID OLc07050 Clone ID Related Accession (Same CDS sequence) XM_001469712.1 Accession Version XM_001469712.1 Latest version! Documents for ORF clone product in default vector Sequence Information ORF Nucleotide Sequence (Length: 795bp)
Protein sequence
SNPVector pcDNA3.1-C-(k)DYK or customized vector 
User ManualClone information Clone Map MSDSTag on pcDNA3.1+/C-(K)DYK C terminal DYKDDDDK tags ORF Insert Method CloneEZ™ Seamless cloning technology Insert Structure linear Update Date 1436889600000 Organism Leishmania infantum JPCM5 Product putative proteasome alpha 1 subunit Comment Comment: PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. This record is derived from an annotated genomic sequence (NC_009420). COMPLETENESS: incomplete on both ends.
1
61
121
181
241
301
361
421
481
541
601
661
721
781ATGTTCAAGA ACGAGTACGA TAGCGACATC ACGACCTGGA GCCCGACGGG CCGGCTCTTT
CAGATCGAGT ATGCGAATGA GGCTGTCAAC AACGGCTCCG CGACGGTTGG CGTGAAAGGG
AGGGACTTTG TCGTGCTCGC CGCACTCAAG CGCAGCCCCG TCGCGGAGCT GTCCTCGTAC
CAAGAAAAGG TCTTCGAGGT TGACGAGCAT GTTGGCATGT CCATCTCGGG CCTCGTGGCG
GATGGCCGCG TGCTTGCTCG CTTCCTGCGC ACAGAATGCA TGAACTACCG CTACATGTAT
AGCCATGGTA TGCCGATGAA TCAAATGGCG GACATGATCG GCGAGAAGCA CCAGCGCCAC
ATCCAATTCA GCGGCAAGCG TCCTTTCGGC GTTGGCCTGC TGCTTGCTGG TTACGATCGC
CAGGGACCGC ACCTGTACCA GACGGTGCCG TCCGGTGACG TTTACGACTA CAAGGCCACG
GCGATGGGCG TGCGCTCGCA GGCGTCCCGC ACGTATTTGG AGAAGCATTT CGAGCACTTC
ACCGACTGCA CCCTCGATGA GCTCGTGGCG CACGCACTGA AGGCCCTCGC TTCCGCGACA
TCGGAGGGCG TGGAGTTGAA TGTAAAGAAC ACCACCATCG CCATCGTAGG CAAGGATACC
CCCTTCACCA TCTTTGAGGA GGAGAGCGCG CGCAGGTACC TGGATGGGTT CAAGATGCGT
CCAGAAGACC GCGTGGCGGC GGCGGACGAT GAGGAGGAGG TTCTGCACGA GCAGCCTCTG
GACGTCGAGG AATAGThe stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.
RefSeq XP_001469749.1 CDS 1..795 Translation 
Target ORF information:
RefSeq Version XM_001469712.1 Organism Leishmania infantum JPCM5 Definition Leishmania infantum JPCM5 putative proteasome alpha 1 subunit partial mRNA. Target ORF information:
Epitope DYKDDDDK Bacterial selection AMPR Mammalian selection NeoR Vector pcDNA3.1+/C-(K)DYK 
XM_001469712.1
ORF Insert Sequence:
1
61
121
181
241
301
361
421
481
541
601
661
721
781ATGTTCAAGA ACGAGTACGA TAGCGACATC ACGACCTGGA GCCCGACGGG CCGGCTCTTT
CAGATCGAGT ATGCGAATGA GGCTGTCAAC AACGGCTCCG CGACGGTTGG CGTGAAAGGG
AGGGACTTTG TCGTGCTCGC CGCACTCAAG CGCAGCCCCG TCGCGGAGCT GTCCTCGTAC
CAAGAAAAGG TCTTCGAGGT TGACGAGCAT GTTGGCATGT CCATCTCGGG CCTCGTGGCG
GATGGCCGCG TGCTTGCTCG CTTCCTGCGC ACAGAATGCA TGAACTACCG CTACATGTAT
AGCCATGGTA TGCCGATGAA TCAAATGGCG GACATGATCG GCGAGAAGCA CCAGCGCCAC
ATCCAATTCA GCGGCAAGCG TCCTTTCGGC GTTGGCCTGC TGCTTGCTGG TTACGATCGC
CAGGGACCGC ACCTGTACCA GACGGTGCCG TCCGGTGACG TTTACGACTA CAAGGCCACG
GCGATGGGCG TGCGCTCGCA GGCGTCCCGC ACGTATTTGG AGAAGCATTT CGAGCACTTC
ACCGACTGCA CCCTCGATGA GCTCGTGGCG CACGCACTGA AGGCCCTCGC TTCCGCGACA
TCGGAGGGCG TGGAGTTGAA TGTAAAGAAC ACCACCATCG CCATCGTAGG CAAGGATACC
CCCTTCACCA TCTTTGAGGA GGAGAGCGCG CGCAGGTACC TGGATGGGTT CAAGATGCGT
CCAGAAGACC GCGTGGCGGC GGCGGACGAT GAGGAGGAGG TTCTGCACGA GCAGCCTCTG
GACGTCGAGG AATAGThe stop codons will be deleted if pcDNA3.1+/C-(K)DYK vector is selected.
-
PubMed
Chromosome and gene copy number variation allow major structural change between species and strains of Leishmania.
Genome research21(12)2129-42(2011 Dec)
Rogers MB,Hilley JD,Dickens NJ,Wilkes J,Bates PA,Depledge DP,Harris D,Her Y,Herzyk P,Imamura H,Otto TD,Sanders M,Seeger K,Dujardin JC,Berriman M,Smith DF,Hertz-Fowler C,Mottram JC
Comparative genomic analysis of three Leishmania species that cause diverse human disease.
Nature genetics39(7)839-47(2007 Jul)
Peacock CS,Seeger K,Harris D,Murphy L,Ruiz JC,Quail MA,Peters N,Adlem E,Tivey A,Aslett M,Kerhornou A,Ivens A,Fraser A,Rajandream MA,Carver T,Norbertczak H,Chillingworth T,Hance Z,Jagels K,Moule S,Ormond D,Rutter S,Squares R,Whitehead S,Rabbinowitsch E,Arrowsmith C,White B,Thurston S,Bringaud F,Baldauf SL,Faulconbridge A,Jeffares D,Depledge DP,Oyola SO,Hilley JD,Brito LO,Tosi LR,Barrell B,Cruz AK,Mottram JC,Smith DF,Berriman M
-
-
Most Popular Services
-
Services & Products
-
News & Blogs
- GenScript’s Codon Optimization faciliates new finding in base editor
- Novel CRISPR-based Non-viral Approach for CAR T Cell Generation
- Small amounts of oil increase the absorption of key nutrients from vegetables
- Successful Clinical Results for a Novel CAR-T Cell Therapy: Is the Cure for Advanced Myeloma Patients within Our Reach?
- Sequencing Analysis to Enable Precise Pediatric Cancer Therapies
- De novo-designed protein switch can be tailored to modulate specific cell signaling pathways
- Suppression of skin-derived circulating factor improves the ability of aging skin to regenerate
- New Technology Paired with NGS, Paves the Way for Novel Therapeutic Antibodies
-
-
-
PubMed
-
